Clinical Trial Update: Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SonoCloud-9 device for transient opening of the blood-brain barrier in first-line temozolomide-treated glioblastoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Initial Radiological Diagnosis Eligible for Tumor Resection, Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type) | Phase 2 | Status: UNKNOWN